Meeting
2023 ASCO Annual Meeting
Clinical and genomic characterisation of adenoid cystic carcinoma of the head and neck, lung, and breast.
Authors
Emily Heathcote
The Christie Hospital NHS Foundation Trust, Manchester, United Kingdom
Emily Heathcote , Karan Patel , Samuel Rack , Clare Hodgson , Hitesh Mistry , Guy Betts , Paul Bishop , Rachel Hall , Anne C. Armstrong , Kevin Joseph Harrington , Robert Metcalf
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Head and Neck Cancer
Track
Head and Neck Cancer
Sub Track
Other Head and Neck Cancer (Salivary, Thyroid)
Citation
J Clin Oncol 41, 2023 (suppl 16; abstr 6094)
DOI
10.1200/JCO.2023.41.16_suppl.6094
Abstract #
6094
Poster Bd #
86
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Annual Meeting
Large-scale comparative analysis of clinico-genomic characteristics, treatment outcomes and resistant mechanisms of ALK/ROS1/RET-rearranged non-small cell lung cancer (NSCLC) in a nationwide genomic screening project (LC-SCRUM-Asia/TRY).
First Author: Yosuke Kagawa
Poster
2023 ASCO Annual Meeting
Association of alterations in multiple tumor suppressor genes with poor outcomes in patients with EGFR-mutant lung cancer.
First Author: Paul Stockhammer
Poster
2023 ASCO Genitourinary Cancers Symposium
Assessing the utility of a cell-free tumor (ct)DNA assay (MSK-ACCESS) in patients (pts) with node-positive (N+) muscle-invasive bladder cancer (MIBC) undergoing neoadjuvant chemotherapy (NAC).
First Author: Andrew B Katims
Poster
2021 ASCO Annual Meeting
Genomic characteristics of breast cancer to predict response of neoadjuvant chemotherapy and long-term prognosis.
First Author: Ji-Yeon Kim